Early or late response in poor responders: does it make a difference in cycle outcome?

References

• Alport, B., Case, A., Lim, H., & Baerwald, A. (2011). Does the ovarian stimulation phase length predict in vitro fertilization outcomes? International Journal of Fertility & Sterility, 5(3), 134–141.
   PubMed Web of Science ®Google Scholar
• Ata, B., & Seli, E. (2015). Strategies for controlled ovarian stimulation in the setting of ovarian aging. Seminars in Reproductive Medicine, 33(6), 436–448. https://doi.org/10.1055/s-0035-1567818
   PubMed Web of Science ®Google Scholar
• Bar-Hava, I., Yoeli, R., Yulzari-Roll, V., Ashkenazi, J., Shalev, J., & Orvieto, R. (2005). Controlled ovarian hyperstimulation: Does prolonged stimulation justify cancellation of in vitro fertilization cycles? Gynecological Endocrinology, 21(4), 232–234. https://doi.org/10.1080/09513590500282331
   PubMed Web of Science ®Google Scholar
• Beloosesky, R., Kol, S., Lightman, A., & Itskovitz-Eldor, J. (2000). Ovarian stimulation in in vitro fertilization with or without the “long” gonadotropin-releasing hormone agonist protocol: Effect on cycle duration and outcome. Fertility and Sterility, 74(1), 166–168. https://doi.org/10.1016/s0015-0282(00)00574-4
   PubMed Web of Science ®Google Scholar
• Chen, S., Sun, L., Kong, L., Li, L., Li, J., Zhu, L., Gao, T., & Xing, F. (2007). Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization. Zhonghua Fu Chan Ke Za Zhi, 42(8), 526–529.
   PubMedGoogle Scholar
• Chuang, M. et al. (2010). Prolonged gonadotropin stimulation is associated with decreased ART success. Journal of Assisted Reproduction and Genetics, 27(12), 711–717.
   PubMed Web of Science ®Google Scholar
• Cicek, M. N., Kahyaoglu, I., & Kahyaoglu, S. (2015). The comparison of microdose flare-up and multiple dose antagonist protocols based on hCG day estradiol (E2), progesterone (P) and P/E2 ratio among poor responder patients in ICSI-ET cycles. European Review for Medical and Pharmacological Sciences, 19(4), 539–544.
   PubMed Web of Science ®Google Scholar
• Cohen, A., Kappy, M., Fazzari, M., Gerber, R. S., Galperin, S., Lieman, H., Jindal, S., & Buyuk, E. (2020). Length of ovarian stimulation does not impact live birth rate in fresh donor oocyte cycles: A SART CORS study. Journal of Assisted Reproduction and Genetics, 37(12), 3033–3038. https://doi.org/10.1007/s10815-020-01972-7
   PubMed Web of Science ®Google Scholar
• Demirdağ, E., Akdulum, M. F. C., Guler, I., Oguz, Y., Erdem, A., & Erdem, M. (2021). IVF outcomes of microdose flare-up, GnRH antagonist, and long protocols in patients having a poor ovarian response in the first treatment cycle. Journal of the College of Physicians and Surgeons–Pakistan, 30(5), 523–527. https://doi.org/10.29271/jcpsp.2021.05.523
   PubMedGoogle Scholar
• Fauser, B. C. (2019). Towards the global coverage of a unified registry of IVF outcomes. Reproductive Biomedicine Online, 38(2), 133–137. https://doi.org/10.1016/j.rbmo.2018.12.001
   PubMed Web of Science ®Google Scholar
• Ferraretti, A. P., La Marca, A., Fauser, B. C. J. M., Tarlatzis, B., Nargund, G., & Gianaroli, L. (2011). ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: The Bologna criteria. Human Reproduction, 26(7), 1616–1624. https://doi.org/10.1093/humrep/der092
   PubMed Web of Science ®Google Scholar
• Hsu, L. T., Chin, T. H., Huang, S. Y., Yang, L. Y., Pan, Y. B., & Chang, C. L. (2021). A short length of gonadotropin hyperstimulation is sufficient to achieve an optimal IVF outcome in advance-aged women. Taiwanese Journal of Obstetrics & Gynecology, 60(6), 1047–1053. https://doi.org/10.1016/j.tjog.2021.09.002
   PubMed Web of Science ®Google Scholar
• Kahyaoglu, I. et al. (2019). Impact of the duration of controlled ovarian stimulation on assisted reproduction cycle outcomes. Gynecology Obstetrics & Reproductive Medicine, 25(1), 28–32.
   Google Scholar
• Kamble, L., Gudi, A., Shah, A., & Homburg, R. (2011). Poor responders to controlled ovarian hyperstimulation for in vitro fertilisation (IVF). Human Fertility, 14(4), 230–245. https://doi.org/10.3109/14647273.2011.608241
   Web of Science ®Google Scholar
• Kerin, J. F., Warnes, G. M., Quinn, P., Kirby, C., Godfrey, B., & Cox, L. W. (1984). Endocrinology of ovarian stimulation for in vitro fertilization. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 24(2), 121–124. https://doi.org/10.1111/j.1479-828x.1984.tb01471.x
   PubMed Web of Science ®Google Scholar
• Kovacs, P., Simpson, S., Cotangco, K., O’Leary, K., & Maxwell, R. (2018). Shorter length of gonadotropin stimulation is associated with adverse IV F outcomes: A retrospective analysis. Journal of Gynecology & Reproductive Medicine, 2(1), 1–6.
   Google Scholar
• Mardešič, T., Mannaerts, B., Abuzeid, M., Levy, M., Witjes, H., & Fauser, B. C. J. M. (2014). Short follicular phase of stimulation following corifollitropin alfa or daily recombinant FSH treatment does not compromise clinical outcome: A retrospective analysis of the engage trial. Reproductive Biomedicine Online, 28(4), 462–468. https://doi.org/10.1016/j.rbmo.2013.12.009
   PubMed Web of Science ®Google Scholar
• Martin, J. R., Mahutte, N. G., Arici, A., & Sakkas, D. (2006). Impact of duration and dose of gonadotrophins on IVF outcomes. Reproductive Biomedicine Online, 13(5), 645–650. https://doi.org/10.1016/s1472-6483(10)60654-2
   PubMed Web of Science ®Google Scholar
• Ozcan Cenksoy, P., Ficicioglu, C., Kizilkale, O., Suhha Bostanci, M., Bakacak, M., Yesiladali, M., & Kaspar, C. (2014). The comparision of effect of microdose GnRH-a flare-up, GnRH antagonist/aromatase inhibitor letrozole and GnRH antagonist/clomiphene citrate protocols on IVF outcomes in poor responder patients. Gynecological Endocrinology, 30(7), 485–489. https://doi.org/10.3109/09513590.2014.893571
   PubMed Web of Science ®Google Scholar
• Patrizio, P., Vaiarelli, A., Levi Setti, P. E., Tobler, K. J., Shoham, G., Leong, M., & Shoham, Z. (2015). How to define, diagnose and treat poor responders? Responses from a worldwide survey of IVF clinics. Reproductive Biomedicine Online, 30(6), 581–592. https://doi.org/10.1016/j.rbmo.2015.03.002
   PubMed Web of Science ®Google Scholar
• Pereira, N., Hobeika, E., Hutchinson, A. P., Lekovich, J., Elias, R., & Rosenwaks, Z. (2015). Prolonged gonadotropin stimulation in fresh in vitro fertilization cycles and its impact on pregnancy outcomes. Fertility and Sterility, 104(3), e328–e329. https://doi.org/10.1016/j.fertnstert.2015.07.1026
   Web of Science ®Google Scholar
• Polyzos, N. P., & Devroey, P. (2011). A systematic review of randomized trials for the treatment of poor ovarian responders: Is there any light at the end of the tunnel? Fertility and Sterility, 96(5), 1058–1061.e7. https://doi.org/10.1016/j.fertnstert.2011.09.048
   PubMed Web of Science ®Google Scholar
• Purandare, N., Emerson, G., Kirkham, C., Harrity, C., Walsh, D., & Mocanu, E. (2017). The duration of gonadotropin stimulation does not alter the clinical pregnancy rate in IVF or ICSI cycles. Irish Journal of Medical Science, 186(3), 653–657. https://doi.org/10.1007/s11845-016-1526-3
   PubMed Web of Science ®Google Scholar
• Royster, G. D., Retzloff, M. G., Robinson, R. D., King, J. A., & Propst, A. M. (2012). Effect of length of controlled ovarian hyperstimulation using a gonadotropin-releasing hormone antagonist on in vitro fertilization pregnancy rates. The Journal of Reproductive Medicine, 57(9–10), 415–420.
   PubMed Web of Science ®Google Scholar
• Ryan, A. et al. (2014). Prolonged gonadotropin stimulation for assisted reproductive technology cycles is associated with decreased pregnancy rates for all women except for women with polycystic ovary syndrome. Journal of Assisted Reproduction and Genetics, 31(7), 837–842.
   PubMed Web of Science ®Google Scholar
• Steptoe, P. C., & Edwards, R. G. (1978). Birth after the reimplantation of a human embryo. The Lancet, 312(8085), 366. https://doi.org/10.1016/S0140-6736(78)92957-4
   Google Scholar
• Tao, T., Robichaud, A., Nadeau, S., Savoie, R., Gallant, B., & Ouellette, R. J. (2006). Optimized hormonal stimulation is critical for production of viable embryos and establishment of subsequent implantation. Journal of Assisted Reproduction and Genetics, 23(1), 23–28. https://doi.org/10.1007/s10815-005-9005-1
   PubMed Web of Science ®Google Scholar
• Wei, Z., Cheng, X., Li, H., Cao, Y., Cong, L., Zhou, P., & Li, J. (2010). Effects of prolonging administration gonadotropin on unexpectedly poor ovarian responders undergoing in vitro fertilization. Reproductive Biology and Endocrinology, 8(1), 26. https://doi.org/10.1186/1477-7827-8-26
   PubMedGoogle Scholar
• Wyndham, N., Marin Figueira, P. G., & Patrizio, P. (2012). A persistent misperception: Assisted reproductive technology can reverse the “aged biological clock. Fertility and Sterility, 97(5), 1044–1047. https://doi.org/10.1016/j.fertnstert.2012.02.015
   PubMed Web of Science ®Google Scholar
• Yang, Y.-C., Li, Y.-P., Pan, S.-P., Chao, K.-H., Chang, C.-H., Yang, J.-H., & Chen, S.-U. (2019). The different impact of stimulation duration on oocyte maturation and pregnancy outcome in fresh cycles with GnRH antagonist protocol in poor responders and normal responders. Taiwanese Journal of Obstetrics & Gynecology, 58(4), 471–476. https://doi.org/10.1016/j.tjog.2019.05.007
   PubMed Web of Science ®Google Scholar
• Yoldemir, T. (2011). Does the duration of gonadotropin stımulation affect embryo quality on post-retrieval day 3? Gynecological Endocrinology, 27(5), 324–330. https://doi.org/10.3109/09513590.2010.491571
   PubMed Web of Science ®Google Scholar